Stockscreener 앱 받기
2.3833
8.33%
-0.2167
전일 마감가:
$2.60
열려 있는:
$2.65
하루 거래량:
3,768
Relative Volume:
0.22
시가총액:
$16.46M
수익:
$22.38M
순이익/손실:
$-13.33M
주가수익비율:
-0.5261
EPS:
-4.53
순현금흐름:
$-8.06M
1주 성능:
-16.96%
1개월 성능:
-16.96%
6개월 성능:
-62.02%
1년 성능:
-49.83%
1일 변동 폭
$2.65
$2.67
1주일 범위
$2.19
$2.9682
52주 변동 폭
$2.19
$7.5498
Ezfill Holdings Inc Stock (EZFL) Company Profile
명칭
Ezfill Holdings Inc
전화
305-791-1169
주소
67 NW 183RD ST, MIAMI
EZFL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| EZFL | 2.67 | 16.46M | 22.38M | -13.33M | -8.06M | -4.53 |
| CRM | 342.22 | 324.58B | 36.47B | 5.63B | 11.46B | 1.59 |
| SAP | 236.50 | 274.15B | 36.09B | 2.98B | 7.67B | 5.2918 |
| NOW | 1,050.31 | 215.85B | 10.46B | 1.34B | 3.35B | 7.72 |
| INTU | 677.94 | 189.18B | 16.29B | 2.96B | 4.63B | 8.44 |
| UBER | 69.59 | 147.99B | 41.96B | 4.40B | 5.96B | -0.22 |
Ezfill Holdings Inc 주식(EZFL)의 최신 뉴스
EzFill stock hits 52-week low at $2.19 amid market challenges By Investing.com - Investing.com South Africa
EZFill Holdings Inc. announced that it has received $0.2 million in funding - Marketscreener.com
EzFill stock hits 52-week low at $2.19 amid market challenges - Investing.com
EzFill secures $181.5K loan with NextNRG Holding By Investing.com - Investing.com UK
EzFill Holdings Reports Strong Q3 2024 Growth - TipRanks
EZFLEzFill Holdings, Inc. Latest Stock News & Market Updates - StockTitan
EzFill Announces 2024 Third Quarter Financial Results - GlobeNewswire
EzFill Q3 Revenue Climbs 13%, Delivers Record 1.87M Gallons Amid Strong Growth | EZFL Stock News - StockTitan
Yoshi Mobility Agrees to Sell Its Fleet Fueling Operation to EZFill Holdings - NGT News
Frist's Yoshi Mobility sells fuel division - The Business Journals
EzFill to acquire Yoshi fueling division, eyes national expansion - Investing.com
EzFill Fueling up to Expand Nationally Enters into LOI for the Acquisition of Yoshi Mobility’s Fuel Division - GlobeNewswire
Yoshi Mobility goes green, spins off fueling division - StockTitan
EZFill Holdings Inc. signed a letter of intent to acquire Fueling division of Yoshi, Inc. - Marketscreener.com
EzFill Mobilizes Fleet Actively Supporting Residents and Businesses Impacted By Major Hurricanes Helene and Milton - GlobeNewswire
EzFill Mobilizes Fleet Actively Supporting Residents and Businesses Impacted By Major Hurricanes Helene and - EIN News
EzFill Holdings revises share exchange in NextNRG acquisition - Investing.com
EzFill Holdings revises share exchange in NextNRG acquisition By Investing.com - Investing.com Canada
EZFill Holdings Inc. (NASDAQ:EZFL) Short Interest Down 56.5% in September - Defense World
FDA Approves Miplyffa for Niemann-Pick Disease, Type C - MyChesCo
FDA Approves Miplyffa for Ultra Rare Niemann-Pick Disease Type C - Managed Healthcare Executive
FDA approves Zevra’s Miplyffa for Niemann-Pick disease type C treatment - World Pharmaceutical Frontiers
EzFill holdings CTO Avishai Vaknin sells shares worth $2300 By Investing.com - Investing.com South Africa
EzFill holdings CTO Avishai Vaknin sells shares worth $2300 - Investing.com
Ezzaty Abdullah admits to be delivering her baby soon - Yahoo Lifestyle Singapore
FDA approves Zevra Therapeutics’ Miplyffa for Niemann-Pick disease - Pharmaceutical Technology
FDA clears first drug for Niemann-Pick disease - pharmaphorum
Zevra’s Miplyffa wins first FDA approval in Niemann-Pick type C - BioWorld Online
EzFill Holdings (NASDAQ:EZFL) Stock Quotes, Forecast and News Summary - Benzinga
After prior snub, Zevra clinches FDA approval for rare lysosomal storage disorder drug Miplyffa - FiercePharma
First Drug Approved for Niemann-Pick Disease Type C - Medpage Today
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease - Benzinga
Arimoclomol Becomes First FDA Approved Treatment for Neimann-Pick Disease Type C - Pharmacy Times
FDA approves first Niemann-Pick disease, type C treatment - The Pharma Letter
FDA approves arimoclomol as first drug to treat Neimann-Pick disease, type C - Contemporary Pediatrics
EZFill Holdings Inc. (NASDAQ:EZFL) CTO Sells $20,550.00 in Stock - Defense World
EzFill holdings CTO Avishai Vaknin sells shares worth nearly $30k By Investing.com - Investing.com South Africa
EzFill holdings CTO Avishai Vaknin sells shares worth nearly $30k - Investing.com India
Extra Storage rises on Jefferies upgrade - XM
EzFill holdings CTO Avishai Vaknin sells shares worth $29,180 - Investing.com India
EzFill holdings CTO Avishai Vaknin sells shares worth $29,180 By Investing.com - Investing.com Australia
Correction to Eli Lilly Gets FDA Approval for Eczema Treatment Article - Morningstar
Eli Lilly Gets FDA Approval for Eczema Treatment Ebglyss - MarketWatch
FDA Approves Eli Lilly's Drug for Eczema - Newsmax
Insider Sale: CTO Avishai Vaknin Sells Shares of EzFill Holdings Inc (EZFL) By GuruFocus - Investing.com Canada
EzFill Holdings CTO Avishai Vaknin sells $74,862 in company stock By Investing.com - Investing.com Canada
EzFill Holdings CTO Avishai Vaknin sells $74,862 in company stock - Investing.com
EzFill holdings CTO Avishai Vaknin sells shares worth over $15k - Investing.com
EzFill regains compliance with Nasdaq's equity rule - Investing.com
EzFill Holdings Regains Nasdaq Compliance, Faces Monitoring - TipRanks
EzFill Holdings, Inc. Regains Compliance with NASDAQ Listing Standard - GlobeNewswire
Ezfill Holdings Inc (EZFL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Ezfill Holdings Inc 주식 (EZFL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Vaknin Avishai | Chief Technology Officer |
Sep 20 '24 |
Sale |
3.45 |
5 |
17 |
65,977 |
| Vaknin Avishai | Chief Technology Officer |
Sep 17 '24 |
Sale |
4.20 |
5,061 |
21,244 |
68,933 |
| Vaknin Avishai | Chief Technology Officer |
Sep 18 '24 |
Sale |
3.72 |
2,246 |
8,354 |
66,626 |
3.15%
1.69%
자본화:
|
볼륨(24시간):